JLL Partners, an American private equity firm, and Water Street Healthcare Partners, a private equity firm, completed the acquisition of Solvias, a provider of commercial physical and biological research and development. Financial terms were not disclosed. "We're thrilled to be growing Solvias in partnership with our new investors and board. Since Solvias' founding, we have continuously innovated and expanded our platform of testing, specialized pharmaceutical manufacturing products, analytical kits and services to offer our customers the highest level of scientific expertise and technical capabilities. These newest initiatives support our goal of bringing greater value to our customers and positioning Solvias at the forefront of our industry," Karen J. Huebscher, Solvias CEO and Director.